GET THE LATEST INTERNATIONAL AND POLITICAL NEWS
Electric vehicle maker Rivian is setting aside its planned partnership with Mercedes-Benz to produce electric vans in Europe so that it can focus on its existing commercial and consumer business. California-based Rivian said Monday it was putting on “pause” the…
Amgen is spending more than $26 billion to dive deeper into rare disease treatments with a deal for drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which…
WASHINGTON — The COVID-19 pandemic laid bare for the District of Columbia and other major cities that public transit was a lifeline for essential workers and that even modest fares could be a burden to them. So the nation’s capital…
A look at some of the key business events and economic indicators upcoming this week: EYE ON INFLATION The Labor Department serves up its November snapshot of inflation at the consumer level Tuesday. Americans continue to face higher costs, reflected…
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion. Each Horizon shareholder will receive $116.50 per share for each share they own. The deal has an enterprise value of…
Ian Millhiser is a senior correspondent at Vox, where he focuses on the Supreme Court, the Constitution, and the decline of liberal democracy in the United States. He received a JD from Duke University and is the author of two…
